Global autoinjectors market expected to generate around USD 137.03 billion by 2025, at a CAGR of around 24.7% between 2019 and 2025. Autoinjectors are medical devices designed to administer a dose of a specific drug to patients. Autoinjectors are proposed for self-administration of drug dosage by patients.
The report covers a forecast and an analysis of the autoinjectors market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints for the autoinjectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the autoinjectors market on a global and regional level.
In order to give the users of this report a comprehensive view of the autoinjectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the autoinjectors market on a global and regional basis.
The study provides a decisive view of the autoinjectors market by segmenting the market based on type, technology, therapy, design, end-user, and region. By type, the autoinjectors market is segmented into reusable autoinjectors and disposable autoinjectors. The technology segment includes manual autoinjectors and automated autoinjectors. The therapy segment includes multiple sclerosis, rheumatoid arthritis, anaphylaxis, diabetes, and others. The design segment includes customized autoinjectors and standardized autoinjectors. The end-user segment includes hospital and clinics and home care settings.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries, such as the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some key players of the global autoinjectors market include Eli Lilly, Abbvie, Biogen, Teva, Mylan, Merck, Ypsomed, SHL Group, Becton Dickinson and Company, and Novartis, among others.
This report segments the global autoinjectors market into:
Global Autoinjectors Market: By Type
Global Autoinjectors Market: By Technology
Global Autoinjectors Market: By Therapy
Global Autoinjectors Market: By Design
Global Autoinjectors Market: By End-User
Global Autoinjectors Market: By Region
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed